Роль микроокружения в развитии и прогрессии рака поджелудочной железы

Роль микроокружения в развитии и прогрессии рака поджелудочной железы

Автор: Окладникова Евгения Владимировна, Рукша Татьяна Геннадьевна

Журнал: Сибирский онкологический журнал @siboncoj

Рубрика: Обзоры

Статья в выпуске: 3 (75), 2016 года.

Бесплатный доступ

Рак поджелудочной железы обладает быстрым инвазивным ростом, ранней склонностью к метастазированию и плохо поддается химиотерапии. Ипользование таргетных препаратов пока не позволило добиться значительных успехов в борьбе с раком поджелудочной железы. Одним из перспективных направлений молекулярной онкологии последних лет является изучение микроокружения опухоли для осуществления целенаправленного воздействия. В представленном обзоре обсуждаются морфофункциональные особенности микроокружения опухоли поджелудочной железы, а также механизмы межклеточных коммуникаций. Изучение данной темы актуально для разработки новых методов терапии рака поджелудочной железы.

Еще

Рак поджелудочной железы, микроокружение опухоли

Короткий адрес: https://sciup.org/14056691

IDR: 14056691   |   DOI: 10.21294/1814-4861-2016-15-3-82-90

Список литературы Роль микроокружения в развитии и прогрессии рака поджелудочной железы

  • Ельникова А.А. Микроокружение опухоли -темная лошадка в противоопухолевой химиотерапии//Здоровье и образование в XXI веке. 2015. Т. 17, № 1. С. 84-86
  • Монастырская Е.А., Лямина С.В., Малышев И.Ю. М1 и М2 фенотипы активированных макрофагов и их роль в иммунном ответе и патологии//Патогенез. 2008. Т. 6, № 4. С. 31-39
  • Состояние онкологической помощи населению России в 2013 году/Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М., 2014. 235 с
  • AlachkarH.,SanthanamR.,MaharryK.,Metzeler K.H.,HuangX.,Kohlschmidt J., Mendler J.H., Benito J.M., Hickey C., Neviani P., Dorrance A.M., Anghelina M., Khalife J., Tarighat S.S.,Volinia S., Whitman S.P., Paschka P., Hoellerbauer P., Wu Y.Z., Han L., Bolon B.N., BlumW., Mrózek K., Car-roll A.J., Perrotti D., Andreeff M., Caligiuri M.A., Konopleva M., Garzon R., Bloomfield C.D, Marcucci G. SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome//J. Clin. Invest. 2014. Vol. 124 (4). P. 1512-1524 DOI: 10.1172/JCI70921
  • Apte M.V., Pirola R.C., Wilson J.S. The fibrosis of chronic pancreatitis: new insights into the role of pancreatic stellate cells//Antioxid. Redox. Signal. 2011. Vol. 15 (10). P. 2711-2722 DOI: 10.1089/ars.2011.4079
  • Apte M.V., Xu Z., Pothula S., Goldstein D., Pirola R.C., Wilson J.S. Pancreatic cancer: The microenvironment needs attention too!//Pancreatology. 2015. Vol. 15 (4 Suppl). S. 32-38 DOI: 10.1016/j.pan.2015.02.013
  • Apte M.V., Wilson J.S., Lugea A., Pandol S.J. A starring role for stellate cells in the pancreatic cancer microenvironment//Gastroenterology. 2013. Vol. 144 (6). P. 1210-1219 DOI: 10.1053/j.gastro.2012.11.037
  • Berchtold S., Grünwald B., Krüger A., Reithmeier A., Hähl T., Cheng T., Feuchtinger A., Born D., Erkan M., Kleeff J., Esposito I. Collagen type V promotes the malignant phenotype of pancreatic ductal adenocarcinoma//Cancer Lett. 2015. Vol. 356 (2 Pt B). P. 721-732 DOI: 10.1016/j.canlet.2014.10.020
  • Bosco M.C., Puppo M., Blengio F., Fraone T., Cappello P., Giovarelli M., Varesio L. Monocytes and dendritic cells in a hypoxic environment: Spotlights on chemotaxis and migration//Immunobiology. 2008. Vol. 213 (9-10). P. 733-749 DOI: 10.1016/j.imbio.2008.07.031
  • Brandes F., Schmidt K., Wagner C., Redekopf J., Schlitt H.J., Geissler E.K., Lang S.A. Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model//BMC Cancer. 2015. Vol. 15. P. 71 DOI: 10.1186/s12885-015-1064-9
  • Brennen W.N., Isaacs J.T., Denmeade S.R. Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy//Mol. Cancer Ther. 2012. Vol. 11 (2). P. 257-266 DOI: 10.1158/1535-7163.MCT-11-0340
  • Brentnall T.A. Arousal of cancer-associated stromal fibroblasts: palladin-activated fibroblasts promote tumor invasion//Cell Adh. Migr. 2012. Vol. 6 (6). P. 488-494 DOI: 10.4161/cam.21453
  • Buscail L., Bournet B., Dufresne M., Torrisani J., Cordelier P. Advance in the biology of pancreatic of cancer//Bull. Cancer. 2015. Vol. 102 (6 Suppl 1). S53-61 DOI: 10.1016/S0007-4551(15)31218-2
  • CasazzaA., Laoui D., Wenes M., Rizzolio S., Bassani N., Mambretti M., Deschoemaeker S., Van Ginderachter J.A., Tamagnone L., Mazzone M. Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity//Cancer Cell. 2013. Vol. 24 (6). P. 695-709. doi: 10.1016/j. ccr.2013.11.007
  • Cid-Arregui A., Juarez V. Perspectives in the treatment of pancreatic adenocarcinoma//World J. Gastroenterol. 2015. Vol. 21 (31). P. 9297-9316 DOI: 10.3748/wjg.v21.i31.9297
  • Chiorean E.G., Coveler A.L. Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies//Drug Des. Devel. Ther. 2015. Vol. 9. P. 3529-3545 DOI: 10.2147/DDDT.S60328
  • Cohen R., Neuzillet C., Tijeras-Raballand A., Faivre S., de Gramont A., Raymond E. Targeting cancer cell metabolism in pancreatic adenocarcinoma//Oncotarget. 2015. Vol. 6 (19). P. 16832-16847
  • Coleman S.J., Chioni A.M., Ghallab M.,Anderson R.K., Lemoine N.R., Kocher H.M., Grose R.P. Nuclear translocation of FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic cancer cell invasion//EMBO Mol. Med. 2014. Vol. 6 (4). P. 467-481. doi: 10.1002/em-mm.201302698
  • Dangi-Garimella S., Sahai V., Ebine K., Kumar K., Munshi H.G. Threedimensional collagen I promotes gemcitabine resistance in vitro in pancreatic cancer cells through HMGA2-dependent histone acetyltransferase expression//PLoS One. 2013. Vol. 8 (5):e64566. doi: 10.1371/journal.pone.0064566
  • Delitto D., Vertes-George E., Hughes S.J., Behrns K.E., Trevino J.G. C-Met signaling in the development of tumorigenesis and chemoresistance: potential applications in pancreatic cancer//World J. Gastroenterol. 2014. Vol. 20 (26). P. 8458-8470 DOI: 10.3748/wjg.v20.i26.8458
  • Drifka C.R., Tod J., Loeffler A.G., Liu Y., Thomas G.J., Eliceiri K.W., Kao W.J. Periductal stromal collagen topology of pancreatic ductal adenocarcinoma differs from that of normal and chronic pancreatitis//Mod. Pathol. 2015. Vol. 28 (11). P. 1470-1480. doi: 10.1038/modpathol.2015.97
  • Erkan M., Kleeff J., Gorbachevski A., Reiser C., Mitkus T., Esposito I., Giese T., Büchler M.W., Giese N.A., Friess H. Periostin creates a tumorsupportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity//Gastroenterology. 2007. Vol. 132 (4). P. 1447-1464
  • Feig C., Gopinathan A., Neesse A., Chan D.S., Cook N., Tuveson D.A. The pancreas cancer microenvironment//Clin. Cancer Res. 2012. Vol. 18 (16). P. 4266-4276 DOI: 10.1158/1078-0432.CCR-11-3114
  • Garajová I., Le Large T.Y., Frampton A.E., Rolfo C., Voortman J., Giovannetti E. Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer//Biomed. Res. Int. 2014: 678401 DOI: 10.1155/2014/678401
  • Gardian K., Janczewska S., Olszewski W.L., Durlik M. Analysis of pancreatic cancer microenvironment: role of macrophage infiltrates and growth factors expression//J. Cancer. 2012. Vol. 3. P. 285-291 DOI: 10.7150/jca.4537
  • Hwang R.F., Moore T., Arumugam T., Ramachandran V., Amos K.D., Rivera A, Ji B., Evans D.B., Logsdon C.D. Cancer-associated stromal fibroblasts promote pancreatic tumor progression//Cancer Res. 2008. Vol. 68 (3). P. 918-926 DOI: 10.1158/0008-5472.CAN-07-5714
  • Hu H., Jiao F., Han T., Wang L.W. Functional significance of macrophages in pancreatic cancer biology//Tumour Biol. 2015. doi:10.1007/s13277-015-4127-2
  • Infante J.R., Matsubayashi H., Sato N., Tonascia J., Klein A.P., Riall T.A., Yeo C, Iacobuzio-Donahue C., Goggins M. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma//J. Clin Oncol. 2007. Vol. 25 (3). P. 319-325
  • Ino Y., Yamazaki-Itoh R., Shimada K., Iwasaki M., Kosuge T., Kanai Y., Hiraoka N. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer//Br. J. Cancer. 2013. Vol. 108 (4). P. 914-923 DOI: 10.1038/bjc.2013.32
  • Jacob M., Chang L., Puré E. Fibroblast activation protein in remodeling tissues//Curr. Mol. Med. 2012. Vol. (10). P. 1220-1243
  • Jacobetz M.A., Chan D.S., Neesse A., Bapiro T.E., Cook N., Frese K.K., Feig C., Nakagawa T., Caldwell M.E., Zecchini H.I., Lolkema M.P., Jiang P., Kultti A., Thompson C.B., Maneval D.C., Jodrell D.I., Frost G.I., Shepard H.M., Skepper J.N., Tuveson D.A. Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer//Gut. 2013. Vol. 62 (1). P. 112-120 DOI: 10.1136/gutjnl-2012-302529
  • Kawase T., Yasui Y., Nishina S., Hara Y., Yanatori I., Tomiyama Y., Nakashima Y., Yoshida K., Kishi F., Nakamura M., Hino K. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma//BMC Gastroenterol. 2015. Vol. 15 (1). P. 109 DOI: 10.1186/s12876-015-0340-0
  • Lee H.O., Mullins S.R., Franco-Barraza J., Valianou M., Cukierman E., Cheng J.D. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells//BMC Cancer. 2011. Vol. 11. P. 245 DOI: 10.1186/1471-2407-11-245
  • Liu C., Yu S., Zinn K., Wang J., Zhang L., Jia Y., Kappes J.C., Barnes S., Kimberly R.P., Grizzle W.E., Zhang H.G. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function//J. Immunol. 2006. Vol. 176 (3). P. 1375-1385
  • Liu Y., Du L. Role of pancreatic stellate cells and periostin in pancreatic cancer progression//Tumour Biol. 2015. Vol. 36 (5). P. 3171-3177 DOI: 10.1007/s13277-015-3386-2
  • Masamune A., Shimosegawa T. Pancreatic stellate cells: Adynamic player of the intercellular communication in pancreatic cancer//Clin. Res. Hepatol. Gastroenterol. 2015. Vol. 39 (Suppl. 1). S. 98-103. doi: 10.1016/j. clinre.2015.05.018
  • Mews P., Phillips P., Fahmy R., Korsten M., Pirola R., Wilson J., Apte M. Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis//Gut. 2002. Vol. 50 (4). P. 535-541
  • Mielgo A., Schmid M.C. Impact of tumour associated macrophages in pancreatic cancer//BMB Rep. 2013. Vol. 46 (3). P. 131-138
  • Nakamura T., Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine//Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2010. Vol. 86 (6). P. 588-610
  • Neesse A., Algül H., Tuveson D.A., Gress T.M. Stromal biology and therapy in pancreatic cancer: a changing paradigm//Gut. 2015. Vol. 64 (9). P. 1476-1484 DOI: 10.1136/gutjnl-2015-309304
  • Neuzillet C., Tijeras-Raballand A., Cros J., Faivre S., Hammel P., Raymond E. Stromal expression of SPARC in pancreatic adenocarcinoma//Cancer Metastasis Rev. 2013. Vol. 32 (3-4). P. 585-602. doi: 10.1007/s10555-013-9439-3
  • Ninichuk V., Gross O., Reichel C., Khandoga A., Pawar R.D., Ciubar R., Segerer S., Belemezova E., Radomska E., Luckow B., Perez de Lema G., Murphy P.M., Gao J.L., Henger A., Kretzler M., Horuk R., Weber M., Krombach F., Schlöndorff D., Anders H.J. Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease//J. Am. Soc. Nephrol. 2005. Vol. 16 (4). P. 977-985
  • Özdemir B.C., Pentcheva-Hoang T., Carstens J.L., Zheng X., Wu C.C., Simpson T.R., Laklai H., Sugimoto H., Kahlert C., Novitskiy S.V., De Jesus-Acosta A., Sharma P., Heidari P., Mahmood U., Chin L., Moses H.L., Weaver V.M., Maitra A., Allison J.P., LeBleu V.S., Kalluri R. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival//Cancer Cell. 2014. Vol. 25 (6). P. 719-734 DOI: 10.1016/j.ccr.2014.04.005
  • Pan B., Liao Q., Niu Z., Zhou L., Zhao Y. Cancer-associated fibroblasts in pancreatic adenocarcinoma//Future Oncol. 2015. Vol. 11 (18). P. 2603-2610 DOI: 10.2217/FON.15.176
  • Pang W., Su J., Wang Y., Feng H., Dai X., Yuan Y., Chen X., Yao W. Pancreatic cancer-secreted miR-155 implicates in the conversion from normal fibroblasts to cancer-associated fibroblasts//Cancer Sci. 2015. Vol. 106 (10). P. 1362-1369 DOI: 10.1111/cas.12747
  • Qian L.W., Mizumoto K., Maehara N., Ohuchida K., Inadome N., Saimura M., Nagai E., Matsumoto K., Nakamura T., Tanaka M. Co-cultivation of pancreatic cancer cells with orthotopic tumor-derived fibroblasts: fibroblasts stimulate tumor cell invasion via HGF secretion whereas cancer cells exert a minor regulative effect on fibroblasts HGF production//Cancer Lett. 2003. Vol. 190 (1). P. 105-112
  • Rhim A.D., Oberstein P.E., Thomas D.H., Mirek E.T., Palermo C.F., Sastra S.A., Dekleva E.N., Saunders T., Becerra C.P., Tattersall I.W., Westphalen C.B., Kitajewski J., Fernandez-Barrena M.G., Fernandez-Zapico M.E., Iacobuzio-Donahue C., Olive K.P., Stanger B.Z. Stromal elementsact to restrain, rather than support, pancreatic ductal adenocarcinoma//Cancer Cell. 2014. Vol. 25 (6). P. 735-747 DOI: 10.1016/j.ccr.2014.04.021
  • Rizwani W., Allen A.E., Trevino J.G. Hepatocyte growth factor from a clinical perspective: a pancreatic cancer challenge//Cancers (Basel). 2015. Vol. 7 (3). P. 1785-1805
  • Rucki A.A., Zheng L. Pancreatic cancer stroma: Understanding biology leads to new therapeutic strategies//World J. Gastroenterol. 2014. Vol. 20 (9). P. 2237-2246 DOI: 10.3748/wjg.v20.i9.2237
  • Sato N., Maehara N., Goggins M. Gene expression profiling of tumor-stromal interactions between pancreatic cancer cells and stromal fibroblasts. Cancer Res. 2004. Vol. 64 (19). P. 6950-6956
  • Schmid-Kotsas A., Gross H.J., Menke A., Weidenbach H., Adler G., Siech M., Beger H., Grünert A., Bachem M.G. Lipopolysaccharide-activated macrophages stimulate the synthesis of collagen type I and C-fibronectin in cultured pancreatic stellate cells//Am. J. Pathol. 1999. Vol. 155 (5). P. 1749-1758
  • Sherman M.H., Yu R.T., Engle D.D., Ding N., Atkins A.R., Tiriac H., Collisson E.A., Connor F., Van Dyke T., Kozlov S., Martin P., Tseng T.W., Dawson D.W., Donahue T.R., Masamune A., Shimosegawa T., Apte M.V., Wilson J.S., Ng B., Lau S.L., Gunton J.E., Wahl G.M., Hunter T., Drebin J.A., O’Dwyer P.J., Liddle C., Tuveson D.A., Downes M., Evans R.M. Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy//Cell. 2014. Vol. 159 (1). P. 80-93 DOI: 10.1016/j.cell.2014.08.007
  • Shi M., Yu D.H., Chen Y., Zhao C.Y., Zhang J., Liu Q.H., Ni C.R., Zhu M.H. Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance//World J. Gastroenterol. 2012. Vol. 18 (8). P. 840-846 DOI: 10.3748/wjg.v18.i8.840
  • Sinn M., Sinn B.V., Striefler J.K., Lindner J.L., Stieler J.M., Lohneis P., Bischoff S., Bläker H., Pelzer U., Bahra M., Dietel M., Dörken B., Oettle H., Riess H., Denkert C. SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study//Ann. Oncol. 2014 Vol. 25 (5). P. 1025-1032. doi: 10.1093/annonc/mdu084
  • Sugimoto M., Mitsunaga S., Yoshikawa K., Kato Y., Gotohda N., Takahashi S., Konishi M., Ikeda M., Kojima M., Ochiai A., Kaneko H. Prognostic impact of M2 macrophages at neural invasion in patients with invasive ductal carcinoma of the pancreas//Eur. J. Cancer. 2014. Vol. 50 (11). P. 1900-1908 DOI: 10.1016/j.ejca.2014.04.010
  • Tang Y., Xu X., Guo S., Zhang C., Tang Y., Tian Y., Ni B., Lu B., Wang H. An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma//PLoS One. 2014. Vol. 9 (3): e91551. doi: 10.1371/journal.pone.0091551
  • Vonlaufen A., Joshi S., Qu C., Phillips P.A., Xu Z., Parker N.R., Toi C.S., Pirola R.C., Wilson J.S., Goldstein D., Apte M.V. Pancreatic stellate cells: partners in crime with pancreatic cancer cells//Cancer Res. 2008. Vol. 68 (7). P. 2085-2093 DOI: 10.1158/0008-5472.CAN-07-2477
  • Wang K., Tang J. Tumour-derived exosomes and their roles in cancer//Zhong Nan Da XueXueBao Yi Xue Ban. 2010. Vol. 35 (12). P. 1288-1292 DOI: 10.3969/j.issn.1672-7347.2010.12.015
  • Whatcott C.J., Diep CH, Jiang P, Watanabe A., LoBello J., Sima C., Hostetter G., Shepard H.M., Von Hoff D.D., Han H. Desmoplasia in primary tumors and metastatic lesions of pancreatic cancer//Clin. Cancer Res. 2015. Vol. 21 (15). P. 3561-3568. CCR-14-1051 DOI: 10.1158/1078-0432
  • Xu Z., Pothula S.P., Wilson J.S., Apte M.V. Pancreatic cancer and its stroma: A conspiracy theory//World J. Gastroenterol. 2014. Vol.20 (32). P. 11216-11229 DOI: 10.3748/wjg.v20.i32.11216
Еще
Статья научная
SciUp 2024 © 2024 ©